CVRx (CVRX) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T17:01:54.804Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:01:54.804Z.

Quote observation: 2026-10-06T17:00:39.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -47,638,000
Quote market capitalization: 44,315,026
Total debt · period ending 2026-06-30: 59,390,000
Cash · period ending 2026-06-30: 64,586,000

FMP input reference: e78bbdb3a8988fdd9fdd63a4dcf124b38851ed281a9b1f93071349952e7e00d5

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

CVRX EBITDA Yield Metrics

EBITDA YIELD

N/A

CVRX Competitors' EBITDA Yield

CVRX

CVRx, Inc.

Current

Market Cap

$44.32M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RPID

Rapid Micro Biosystems, Inc.

vs CVRX

Market Cap

$44.41M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NNOX

Nano-X Imaging Ltd.

vs CVRX

Market Cap

$43.78M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BSEM

BioStem Technologies, Inc.

vs CVRX

Market Cap

$42.46M

EBITDA Yield

N/A

TTM Avg

14.45%

3Y Avg

11.70%

5Y Avg

11.70%

SNWV

SANUWAVE Health Inc.

vs CVRX

Market Cap

$43.51M

EBITDA Yield

4.23%

TTM Avg

3.76%

3Y Avg

3.51%

5Y Avg

3.51%

HOWL

Werewolf Therapeutics, Inc.

vs CVRX

Market Cap

$45.20M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DRIO

DarioHealth Corp.

vs CVRX

Market Cap

$45.37M

EBITDA Yield

N/A

TTM Avg

8.08%

3Y Avg

7.24%

5Y Avg

6.66%

PRPO

Precipio, Inc.

vs CVRX

Market Cap

$41.92M

EBITDA Yield

N/A

TTM Avg

0.46%

3Y Avg

0.46%

5Y Avg

0.46%

POCI

Precision Optics Corporation, Inc.

vs CVRX

Market Cap

$47.83M

EBITDA Yield

N/A

TTM Avg

0.84%

3Y Avg

0.84%

5Y Avg

0.84%

FLNA

Filana Therapeutics, Inc.

vs CVRX

Market Cap

$40.44M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
CVRx, Inc. (CVRX)	$44.32M	N/A	N/A	N/A	N/A
Rapid Micro Biosystems, Inc. (RPID)vs ›	$44.41M	N/A	N/A	N/A	N/A
Nano-X Imaging Ltd. (NNOX)vs ›	$43.78M	N/A	N/A	N/A	N/A
BioStem Technologies, Inc. (BSEM)vs ›	$42.46M	N/A	14.45%	11.70%	11.70%
SANUWAVE Health Inc. (SNWV)vs ›	$43.51M	4.23%	3.76%	3.51%	3.51%
Werewolf Therapeutics, Inc. (HOWL)vs ›	$45.20M	N/A	N/A	N/A	N/A
DarioHealth Corp. (DRIO)vs ›	$45.37M	N/A	8.08%	7.24%	6.66%
Precipio, Inc. (PRPO)vs ›	$41.92M	N/A	0.46%	0.46%	0.46%
Precision Optics Corporation, Inc. (POCI)vs ›	$47.83M	N/A	0.84%	0.84%	0.84%
Filana Therapeutics, Inc. (FLNA)vs ›	$40.44M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

CVRX EBITDA Yield Metrics

CVRX Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics